| Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial Y Cao, J Wei, L Zou, T Jiang, G Wang, L Chen, L Huang, F Meng, ... Journal of Allergy and Clinical Immunology 146 (1), 137-146. e3, 2020 | 498 | 2020 |
| Elevated serum levels of S100A8/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients L Chen, X Long, Q Xu, J Tan, G Wang, Y Cao, J Wei, H Luo, H Zhu, ... Cellular & molecular immunology 17 (9), 992-994, 2020 | 244 | 2020 |
| Efficacy and safety of CAR19/22 T-cell cocktail therapy in patients with refractory/relapsed B-cell malignancies N Wang, X Hu, W Cao, C Li, Y Xiao, Y Cao, C Gu, S Zhang, L Chen, ... Blood, The Journal of the American Society of Hematology 135 (1), 17-27, 2020 | 221 | 2020 |
| Integrated genomic analysis identifies deregulated JAK/STAT-MYC-biosynthesis axis in aggressive NK-cell leukemia L Huang, D Liu, N Wang, S Ling, Y Tang, J Wu, L Hao, H Luo, X Hu, ... Cell research 28 (2), 172-186, 2018 | 81 | 2018 |
| Potential application of IDH1 and IDH2 mutations as prognostic indicators in non-promyelocytic acute myeloid leukemia: a meta-analysis KG Zhou, LJ Jiang, Z Shang, J Wang, L Huang, JF Zhou Leukemia & lymphoma 53 (12), 2423-2429, 2012 | 71 | 2012 |
| Inflammatory signatures for quick diagnosis of life-threatening infection during the CAR T-cell therapy H Luo, N Wang, L Huang, X Zhou, J Jin, C Li, D Wang, B Xu, J Xu, L Jiang, ... Journal for immunotherapy of cancer 7, 1-11, 2019 | 57 | 2019 |
| Aggressive NK-cell leukemia: clinical subtypes, molecular features, and treatment outcomes YT Tang, D Wang, H Luo, M Xiao, HS Zhou, D Liu, SP Ling, N Wang, ... Blood cancer journal 7 (12), 660, 2017 | 52 | 2017 |
| Severe early hepatitis B reactivation in a patient receiving anti-CD19 and anti-CD22 CAR T cells for the treatment of diffuse large B-cell lymphoma J Wei, X Zhu, X Mao, L Huang, F Meng, J Zhou Journal for ImmunoTherapy of Cancer 7, 1-5, 2019 | 50 | 2019 |
| DEPTOR is a direct NOTCH1 target that promotes cell proliferation and survival in T-cell leukemia Y Hu, H Su, C Liu, Z Wang, L Huang, Q Wang, S Liu, S Chen, J Zhou, P Li, ... Oncogene 36 (8), 1038-1047, 2017 | 49 | 2017 |
| A phase I study of anti‐BCMA CAR T cell therapy in relapsed/refractory multiple myeloma and plasma cell leukemia C Li, W Cao, Y Que, Q Wang, Y Xiao, C Gu, D Wang, J Wang, L Jiang, ... Clinical and translational medicine 11 (3), e346, 2021 | 48 | 2021 |
| Mutations or copy number losses of CD58 and TP53 genes in diffuse large B cell lymphoma are independent unfavorable prognostic factors Y Cao, T Zhu, P Zhang, M Xiao, S Yi, Y Yang, Q Li, S Ling, Y Wang, L Gao, ... Oncotarget 7 (50), 83294, 2016 | 47 | 2016 |
| Small molecule activation of NOTCH signaling inhibits acute myeloid leukemia Q Ye, J Jiang, G Zhan, W Yan, L Huang, Y Hu, H Su, Q Tong, M Yue, H Li, ... Scientific Reports 6 (1), 26510, 2016 | 45 | 2016 |
| Targeting PD-1/PD-L1 pathway in myelodysplastic syndromes and acute myeloid leukemia X Yang, L Ma, X Zhang, L Huang, J Wei Experimental Hematology & Oncology 11 (1), 11, 2022 | 42 | 2022 |
| CD19/CD22 chimeric antigen receptor T cell cocktail therapy following autologous transplantation in patients with relapsed/refractory aggressive B cell lymphomas Y Cao, Y Xiao, N Wang, G Wang, L Huang, Z Hong, L Meng, X Zhou, ... Transplantation and cellular therapy 27 (11), 910. e1-910. e11, 2021 | 42 | 2021 |
| Transmembrane TNF-α preferentially expressed by leukemia stem cells and blasts is a potent target for antibody therapy X Zhou, S Zhou, B Li, Q Li, L Gao, D Li, Q Gong, L Zhu, J Wang, N Wang, ... Blood, The Journal of the American Society of Hematology 126 (12), 1433-1442, 2015 | 41 | 2015 |
| Abnormal immunophenotype provides a key diagnostic marker: a report of 29 cases of de novo aggressive natural killer cell leukemia C Li, Y Tian, J Wang, L Zhu, L Huang, N Wang, D Xu, Y Cao, J Li, J Zhou Translational Research 163 (6), 565-577, 2014 | 41 | 2014 |
| Anti-BCMA CAR T-cell therapy CT103A in relapsed or refractory AQP4-IgG seropositive neuromyelitis optica spectrum disorders: phase 1 trial interim results C Qin, DS Tian, LQ Zhou, K Shang, L Huang, MH Dong, YF You, J Xiao, ... Signal Transduction and Targeted Therapy 8 (1), 5, 2023 | 35 | 2023 |
| CAR T-cell therapy is effective but not long-lasting in B-cell lymphoma of the brain T Li, L Zhao, Y Zhang, Y Xiao, D Wang, L Huang, L Ma, L Chen, S Liu, ... Frontiers in Oncology 10, 1306, 2020 | 35 | 2020 |
| Effects of cryopreservation on chimeric antigen receptor T cell functions H Xu, W Cao, L Huang, M Xiao, Y Cao, L Zhao, N Wang, J Zhou Cryobiology 83, 40-47, 2018 | 35 | 2018 |
| Stabilization of Notch1 by the Hsp90 chaperone is crucial for T-cell leukemogenesis Z Wang, Y Hu, D Xiao, J Wang, C Liu, Y Xu, X Shi, P Jiang, L Huang, P Li, ... Clinical Cancer Research 23 (14), 3834-3846, 2017 | 35 | 2017 |
